North America Epilepsy Monitoring Devices Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 659.99 |
 CAGR |
% |
| Major Markets Players |
North America Epilepsy Monitoring Devices Market, By Product Type (Wearable Devices, Smart Devices, and Conventional Devices), Type (Focal Seizures, and Generalized Seizures), Patient Type (Paediatric, Geriatric, and Adults), End User (Hospitals, Homecare Setting, Neurology Centres, Diagnostic Centres, Ambulatory Surgical Centres & Clinics, and Others), Distribution Channel (Retail Sales, Online Sales, Direct Tenders, and Others) - Industry Trends and Forecast to 2030.
North America Epilepsy Monitoring Devices Market Analysis Size
The increasing demand for wearable epilepsy monitoring devices is helping to boost the overall market growth. The growing government investments in epilepsy projects also contribute to market growth. The major market players are highly focused on developing various new epilepsy monitoring devices. In addition, the rising prevalence of epilepsy is also contributing to the rising demand for the market.
North America epilepsy monitoring devices market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyzes that the market is growing with a CAGR of 5.8% in the forecast period of 2023 to 2030 and is expected to reach USD 659.99 million by 2030.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Year |
2021 (Customizable to 2020-2015) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
By Product Type (Wearable Devices, Smart Devices, and Conventional Devices), Type (Focal Seizures, and Generalized Seizures), Patient Type (Paediatric, Geriatric, and Adults), End User (Hospitals, Homecare Setting, Neurology Centres, Diagnostic Centres, Ambulatory Surgical Centres & Clinics, and Others), Distribution Channel (Retail Sales, Online Sales, Direct Tenders, and Others) |
|
Countries Covered |
U.S., Canada and Mexico |
|
Market Players Covered |
NIHON KOHDEN CORPORATION., Masimo, Apple Inc., Natus Medical Incorporated., Owlet, Neurotech, LLC, SmartMonitor, and Epilert, among others.
|
Market Definition
Epilepsy is a central nervous system (neurological) disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations and sometimes loss of awareness. Epileptic seizures can vary from brief and nearly undetectable periods to long periods of vigorous shaking due to abnormal electrical activity in the brain. The most common type of seizure is convulsive, which involves involuntary muscle contractions.
Tonic-clonic seizures occur with a contraction of the limbs followed by their extension and arching of the back, which lasts 10–30 seconds. Myoclonic seizures involve very brief spasms of muscles in either a few areas or all over.
North America Epilepsy Monitoring Devices Market Dynamics
Drivers
-
Rising prevalence of epilepsy
Epilepsy is a neurological condition that causes unprovoked, recurrent seizures. A seizure is a sudden rush of abnormal electrical activity in the brain. Doctors diagnose epilepsy when someone has two or more seizures with no other identifiable cause. Anyone can develop epilepsy, but it most commonly onsets in young and older adults. A mild seizure may be difficult to recognize. It may only last a few seconds, and the individual may remain awake while it happens. Stronger seizures can cause spasms and uncontrollable muscle twitches. They can last from a few seconds to several minutes and may cause confusion or loss of consciousness. Afterward, the individual may have no memory of a seizure happening.
Epilepsy has become the world’s most common neurological disorder among every age group. As epilepsy can be treated if diagnosed early, people with epilepsy symptoms are more focused on its diagnosis & treatment by using various technologically advanced monitoring devices. As a result, the demand for epilepsy monitoring devices is increasing & hence, the rising prevalence of epilepsy is driving the growth of the North America epilepsy monitoring devices market.
-
Growing preference for wearable epilepsy monitoring devices
It is a major challenge in clinical epilepsy to diagnose and treat a disease characterized by infrequent seizures based on patient or caregiver reports and limited-duration clinical testing. The poor reliability of self-reported seizure diaries for many people with epilepsy is well-established, but these records remain necessary in clinical care and therapeutic studies.
Several wearable devices have emerged which are capable of detecting seizures, recording seizure data and alerting caregivers. Wearable devices may also facilitate reliable forecasts of seizure likelihood, providing the potential for people with epilepsy to take fast-acting medications or modify activities in anticipation of an impending seizure. Therefore, wearable sensing devices are increasing in popularity both in the general community & through medical applications. Hence, the growing preference for wearable epilepsy monitoring devices is driving the growth of the North America epilepsy monitoring devices market.
-
Rising government investments in the epilepsy project
Epilepsy has become the world’s most common neurological disorder, and so has the mortality rate. Research on the underlying causes of epilepsies, including the identification of genes for some forms of epilepsy, has led to a greatly improved understanding of these disorders that may lead to treatments that are more effective or even to new ways of preventing epilepsy in the future.
Government is more focused on fewer deaths, a better quality of life for patients suffering from epilepsy and fewer seizures. This can be possible with the combination of advanced imaging, cognitive and genetic data, personalized treatment plans and a skilled surgical team where necessary. Hence, the government is investing more in epilepsy projects to enhance the infrastructure and better care for patients. Therefore, it can be a driving factor for the growth of the North America epilepsy monitoring devices market.
Opportunities
-
Rise in technological advancement in the disease monitoring device
With the advent of time, medical devices have undergone various technological changes. The advancement in disease-monitoring medical devices includes using flexible electronics such as thin flaps or skin patches for the accurate and real-time monitoring of vital signs. The validation and accuracy of the recorded data by such devices are also enhanced by the upgradation of new operating software and hardware used in those devices. The advanced flaps-like monitoring system is manufactured by various key market leaders like Neurava, Neuronostics, Epilepsy Alarms and others. Instant and precise assessment of results coupled with the noteworthy existence of these devices due to advancements; escalate the customer preference and adoption rate of such devices. Thus, innovations leading to superior product characteristics and cost-effectivity will spur North America market expansion of epilepsy monitoring devices.
The innovation and advancement in technology have upgraded medical devices in all prospects, including battery life, light weightiness, advanced features like AI assistance, upgraded software, and wireless connectivity, among more. Technological advancement brings many advantages to the patient’s diagnosis and therapeutic uses with improvements in remote monitoring systems. Thus, the increased technological advancement boosts the growth of the North America epilepsy monitoring devices market.
-
Increased demand for the non-invasive and minimally invasive device
An invasive device is a complicated, painful, and risky procedure, as it involves direct intervention with the brain tissue. Therefore, healthcare professionals and patients show a high inclination towards the use of non-invasive and minimally invasive devices. With rising awareness, more patients are opting for minimally invasive or non-invasive procedures. Epilepsy monitoring devices overcome the risks and pain associated with invasive brain monitoring. Many government initiatives also focus on reducing the risks related to treatment options for brain disorders.
Restraints/Challenges
- Poor reimbursement scenario
Reimbursement for all healthcare devices and services has been under downward pressure for several years. These devices also face a major roadblock in their growth due to the lack of reimbursement of these devices. The combination of wearable devices with AI, irrelevant data collection and security issues of medical devices pose a significant impact on these devices that leads to difficulty in a gain of reimbursement for such devices. The reimbursement of a device can significantly affect the ability of a provider to access a particular technology, as well as the willingness of a manufacturer to deliver it. If coverage is uncertain, the manufacturer has difficulty predicting whether an investment in new technology will yield enough returns. This lack of predictability is an apparent barrier to obtaining funding for the company. It further compromises innovation and restricts patient access to advanced technology and solutions.
Monitoring devices have become an important part of healthcare in terms of diagnosis and prognosis of chronic diseases. The increased application of monitoring devices in conditions like neurological, diabetes, obesity and cardiovascular issues, among more, makes it crucial for the healthcare facility. However, the high cost of such devices and the lack of proper reimbursement hampers the adoption rate of these medical devices. Thus, the lack of reimbursement acts as a challenge to the growth of the North America epilepsy monitoring market.
Post-COVID-19 Impact on North America Molecular Diagnostics Services Market
The post-COVID-19 has negatively affected the market. A large number of the population were affected by this pandemic. The supply of ophthalmic products has suffered a massive hit due to the North America pandemic of COVID-19. This reduction in supply is mainly due to various quarantine policies adopted by countries worldwide. This, along with the restrictions of movement and labor reduction, are the major reasons for a decreasing trend in the supply market of medical devices. This has affected the quality and efficacy of medical devices to a high extent. Reduction in the headcount of the labor force due to COVID-19 affliction is another factor contributing to the reduced supply of epilepsy monitoring devices.
Recent Developments
- In December 2022, NIHON KOHDEN CORPORATION announced that it would open a new sale branch of Nihon Kohden Singapore (NKS), one of its sales subsidiaries, aiming to apply for registration of medical devices smoothly and expand its sales in the Philippines
- In February 2022, Masimo announced its entry into a definitive merger agreement to acquire Viper Holdings Corporation, which owns Sound United (“Sound United”). This consumer technology company owns a portfolio of premium brands, including Bowers& Wilkins, Denon, Polk Audio and Marantz. Pursuant to the merger agreement, they had to pay approximately USD 1.025 billion, subject to adjustments, for the acquisition. This helps the organization generate more revenue
North America Epilepsy Monitoring Devices Market Scope
The North America epilepsy monitoring devices market is segmented into five notable segments based on product type, type, patient type, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
By Product Type
- Wearable Devices
- Smart Devices
- Conventional Devices
On the basis of product type, the market is segmented into wearable devices, smart devices and conventional devices.
By Type
- Focal Seizures
- Generalized Seizures
On the basis of type, the market is segmented into focal seizures & generalized seizures.
By Patient Type
- Pediatric
- Geriatric
- Adults
On the basis of patient type, the market is segmented into pediatric, geriatric and adults.
By End User
- Hospitals
- Homecare Setting
- Neurology Centres
- Diagnostic Centres
- Ambulatory Surgical Centres & Clinics
- Others
On the basis of end users, the market is segmented into hospitals, homecare settings, neurology centres, diagnostic centres, ambulatory surgical centres & clinics and others.
By Distribution Channel
- Retail Sales
- Online Sales
- Direct Tenders
- Others
On the basis of distribution channel, the market is segmented into retail sales, online sales, direct tenders and others.
North America Epilepsy Monitoring Devices Market Regional Analysis/Insights
The North America epilepsy monitoring devices market is analyzed, and market size insights and trends are provided by country, product type, type, patient type, end user and distribution channel.
Countries covered in North America epilepsy monitoring devices market are U.S., Canada, Mexico.
U.S. dominates the North America epilepsy monitoring devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period.
The country section of the report also provides individual market-impacting factors and changes in regulations in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands impact on sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and North America Epilepsy Monitoring Devices Market Share Analysis
The North America epilepsy monitoring devices market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies focus on the market.
Some of the major players operating in the North America epilepsy monitoring devices market are NIHON KOHDEN CORPORATION., Masimo, Apple Inc., Natus Medical Incorporated., Owlet, Neurotech, LLC, SmartMonitor, and Epilert, among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PREMIUM INSIGHTS
4.1.1 KEY STRATEGIC INITIATIVES
4.1.2 SEIZURES OCCURRENCE, BY TIME
4.1.2.1 DURING DAY
4.1.2.2 DURING SLEEP
4.1.2.2.1 RAPID EYE MOVEMENT (REM) SLEEP
4.1.2.2.2 NON-REM SLEEP
4.1.2.3 DURING NIGHT
5 EPIDEMIOLOGY
5.1 INCIDENCE & PREVALENCE OF EPILEPSY, BY COUNTRY
5.1.1 GENERALIZED SEIZURES, BY PATIENT TYPE
5.1.1.1 TONIC-CLONIC SEIZURES
5.1.1.2 ABSENCE SEIZURES
5.1.2 FOCAL SEIZURES, BY PATIENT TYPE
5.1.2.1 SIMPLE FOCAL SEIZURES
5.1.2.2 COMPLEX FOCAL SEIZURES
5.1.2.3 SECONDARY GENERALIZED SEIZURES
6 NORTH AMERICA EPILEPSY MONITORING DEVICE MARKET, REGULATORY FRAMEWORK
6.1 MEDICAL DEVICES
6.2 WEARABLE MEDICAL DEVICES
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF EPILEPSY
7.1.2 GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES
7.1.3 RISING GOVERNMENT INVESTMENTS IN THE EPILEPSY PROJECT
7.1.4 INCREASED R & D ACTIVITIES IN EPILEPSY
7.2 RESTRAINTS
7.2.1 HIGH COST ASSOCIATED WITH COMPLEX EPILEPSY MONITORING PROCEDURES & DEVICES
7.2.2 PRODUCT RECALL SCENARIO OF EPILEPSY MONITORING DEVICES
7.3 OPPORTUNITIES
7.3.1 RISE IN TECHNOLOGY ADVANCEMENT IN DISEASE MONITORING DEVICE
7.3.2 INCREASED DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE DEVICE
7.4 CHALLENGES
7.4.1 POOR REIMBURSEMENT SCENARIO
7.4.2 STRINGENT RULES & REGULATIONS FOR PRODUCT APPROVAL
8 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 WEARABLE DEVICES
8.2.1 SMART WATCHES
8.2.2 OTHER NON-INVASIVE MONITORING DEVICES
8.3 SMART DEVICES
8.3.1 MOTION MONITORS
8.3.2 1.3.2 VIDEO MONITORS
8.3.3 MATTRESS DEVICES
8.3.4 OTHERS
8.4 CONVENTIONAL DEVICES
8.4.1 EEG DEVICE
8.4.1.1 AMBULATORY EEG
8.4.1.2 CONTINUOUS EEG
8.4.1.3 OTHER EEG DEVICES
8.4.2 ELECTROMYOGRAPHY (EMG) DEVICE
8.4.3 ELECTROCARDIOGRAM (ECG) DEVICE
8.4.4 PULSE- OXIMETERS
8.4.5 IMPLANTED ADVISORY SYSTEM
8.4.6 TRIAXIAL ACCELEROMETER (ACM)
8.4.7 MAGNETOMETERS
8.4.8 OTHER DEVICES
9 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE
9.1 OVERVIEW
9.2 FOCAL SEIZURES
9.2.1 SIMPLE FOCAL SEIZURES
9.2.1.1 SMART DEVICES
9.2.1.2 WEARABLE DEVICES
9.2.1.3 CONVENTIONAL DEVICES
9.2.2 COMPLEX FOCAL SEIZURES
9.2.2.1 SMART DEVICES
9.2.2.2 WEARABLE DEVICES
9.2.2.3 CONVENTIONAL DEVICES
9.2.3 SECONDARY GENERALIZED SEIZURES
9.2.3.1 SMART DEVICES
9.2.3.2 WEARABLE DEVICES
9.2.3.3 CONVENTIONAL DEVICES
9.3 GENERALIZED SEIZURES
9.3.1 TONIC-CLONIC SEIZURES
9.3.1.1 SMART DEVICES
9.3.1.2 WEARABLE DEVICES
9.3.1.3 CONVENTIONAL DEVICES
9.3.2 ABSENCE SEIZURES
9.3.2.1 SMART DEVICES
9.3.2.2 WEARABLE DEVICES
9.3.2.3 CONVENTIONAL DEVICES
10 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE
10.1 OVERVIEW
10.2 PEDIATRIC
10.3 GERIATRIC
10.4 ADULTS
11 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 HOMECARE SETTINGS
11.4 NEUROLOGY CENTRES
11.5 DIAGNOSTIC CENTRES
11.6 AMBULATORY SURGICAL CENTRES AND CLINICS
11.7 OTHERS
12 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 RETAIL SALES
12.3 ONLINE SALES
12.4 DIRECT TENDERS
12.5 OTHERS
13 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT
16 COMPANY PROFILES
16.1 NIHON KOHDEN CORPORATION.
16.1.1 COMPANY SNAPSHOT
16.1.2 RECENT FINANCIALS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 MASIMO
16.2.1 COMPANY SNAPSHOT
16.2.2 RECENT FINANCIALS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 APPLE INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 NATUS MEDICAL INCORPORATED.
16.4.1 COMPANY SNAPSHOT
16.4.2 RECENT FINANCIALS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 OWLET.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 ACTIGRAPH, LLC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 ADVANCED BRAIN MONITORING, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 CAPTUREPROFF INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 EMPATICA INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 EPIHUNTER
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 EPILERT
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 EPILEPSY ALARMS UK
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 EPI USA.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 EPIVIEW
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 FREQUENCY PRECISION.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 HIPASS DESIGN LLC
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 IBABY LABS, INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 ITS DESIGNS LTD
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 LIVASSURED
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 LIVELIFE ALARMS.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 MEDPAGE LTD
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 MIKU INC.
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 NEUROSOFT
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 NEUROTECH, LLC
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 SAFE-LIFE
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 SMARTMONITOR
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENT
16.27 SNUZA
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENT
16.28 THE ‘LIFE MINDER’
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
16.29 VAHLKAMP INTERNATIONAL B.V.
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 2 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 3 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 4 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION))
TABLE 21 NORTH AMERICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA PEDIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA GERIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA ADULTS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA HOSPITALS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA HOMECARE SETTINGS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA NEUROLOGY CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA DIAGNOSTIC CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA AMBULATORY SURGICAL CENTRES AND CLINIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA RETAIL SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA ONLINE SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA DIRECT TENDERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 42 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 43 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 45 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 46 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 48 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 49 NORTH AMERICA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 51 NORTH AMERICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 52 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 59 NORTH AMERICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 60 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 61 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 62 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 63 U.S. EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 U.S. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 U.S. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 66 U.S. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 67 U.S. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 U.S. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 69 U.S. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 70 U.S. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 71 U.S. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 72 U.S. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 73 U.S. EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 74 U.S. EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 75 U.S. EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 76 U.S. EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 U.S. FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 U.S. SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 U.S. COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 U.S. SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 81 U.S. GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 82 U.S. TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 83 U.S. ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 84 U.S. EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 85 U.S. EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 86 U.S. EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 87 CANADA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 88 CANADA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 89 CANADA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 90 CANADA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 91 CANADA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 92 CANADA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 93 CANADA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 94 CANADA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 95 CANADA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 96 CANADA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 97 CANADA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 CANADA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 99 CANADA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 100 CANADA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 CANADA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 CANADA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 103 CANADA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 104 CANADA SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 105 CANADA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 CANADA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 107 CANADA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 108 CANADA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 109 CANADA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 110 CANADA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 111 MEXICO EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 112 MEXICO WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 MEXICO WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 114 MEXICO WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 115 MEXICO SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 MEXICO SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 117 MEXICO SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 118 MEXICO CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 MEXICO CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 120 MEXICO CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 121 MEXICO EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 MEXICO EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 123 MEXICO EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 124 MEXICO EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 125 MEXICO FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 126 MEXICO SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 MEXICO COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 MEXICO SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 MEXICO GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 MEXICO TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 131 MEXICO ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 132 MEXICO EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 133 MEXICO EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 134 MEXICO EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: DBMR POSITION GRID
FIGURE 8 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: END USER COVERAGE GRID
FIGURE 10 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
FIGURE 11 THE RISING PREVALENCE OF EPILEPSY & GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES ARE EXPECTED TO DRIVE THE NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030
FIGURE 12 THE WEARABLE DEVICE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET
FIGURE 14 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2022
FIGURE 19 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, 2022
FIGURE 23 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2022
FIGURE 27 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022)
FIGURE 35 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022)
FIGURE 36 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: PRODUCT TYPE (2023-2030)
FIGURE 39 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: COMPANY SHARE 2022 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
